Clinical trials
Completed Observational Hepatitis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
41 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 2 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2009 | 5 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 3 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 41 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| National Heart, Lung, and Blood Institute (NHLBI) | 3 |
| AbbVie | 2 |
| All India Institute of Medical Sciences | 2 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2 |
| National Institutes of Health Clinical Center (CC) | 2 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| Beckman Coulter, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Centers for Disease Control and Prevention | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis | 41 |
| Hepatitis C | 8 |
| Hepatitis B | 5 |
| Liver Cirrhosis | 5 |
| Liver Diseases | 4 |
| Virus Diseases | 4 |
| HIV Infections | 3 |
| Hepatitis A | 3 |
| Hepatitis C, Chronic | 3 |
| Carcinoma, Hepatocellular | 2 |
Trials
Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.